BeOne Medicines (ONC) Work In Process (2024 - 2026)

BeOne Medicines (ONC) has reported Work In Process for 3 consecutive years, with $109.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Work In Process changed N/A year-over-year to $109.2 million; the TTM figure through Mar 2026 stood at $109.2 million (changed N/A YoY), while the FY2025 annual figure was $122.7 million, up 104.07% from the prior year.
• Work In Process fell to $109.2 million in Q1 2026 per ONC's latest filing, from $122.7 million in the prior quarter.
• Across five years, Work In Process topped out at $122.7 million in Q4 2025 and bottomed at $60.1 million in Q4 2024.
• Historically, Work In Process has averaged $97.3 million across 3 years, with a median of $109.2 million in 2026.
• On a YoY basis, Work In Process climbed as much as 104.07% in 2025 and fell as far as 104.07% in 2025.
• BeOne Medicines' Work In Process stood at $60.1 million in 2024, then jumped by 104.07% to $122.7 million in 2025, then retreated by 10.98% to $109.2 million in 2026.
• Business Quant data shows ONC's Work In Process at $109.2 million in Q1 2026, $122.7 million in Q4 2025, and $60.1 million in Q4 2024.